Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The preferences of potential stakeholders in psychiatric genomic research regarding consent procedures and information delivery

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Association between prior somatic disease and 5-year relapse risk among 11,856 incident patients with schizophrenia

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Healthy minds 0-100 years: Optimising the use of European brain imaging cohorts ("Lifebrain")

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Platform for systems medicine research and diagnostic applications in psychotic disorders-The METSY project

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Plasma Cotinine Cutoff for Distinguishing Smokers From Nonsmokers Among Persons Living With HIV

    Research output: Contribution to journalJournal articleResearch

  2. The Validity of Daily Self-Assessed Perceived Stress Measured Using Smartphones in Healthy Individuals: Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Genetic Determinants of Weight Loss After Bariatric Surgery

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Storage time of red blood cells among ICU patients with septic shock

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Genomic sequencing plays an increasing role in genetic research, also in psychiatry. This raises challenges concerning the validity and type of the informed consent and the return of incidental findings. However, no solution currently exists on the best way to obtain the informed consent and deliver findings to research subjects.

AIMS: This study aims to explore the attitudes among potential stakeholders in psychiatric genomic research toward the consenting procedure and the delivery of incidental findings.

METHODS: We developed a cross-sectional web-based survey among five groups of stakeholders. A total of 2637 stakeholders responded: 241 persons with a mental disorder, 671 relatives, 1623 blood donors, 74 psychiatrists, and 28 clinical geneticists.

RESULTS: The stakeholders wanted active involvement as 92.7% preferred a specific consent and 85.1% wanted to receive information through a dynamic consent procedure. The majority of stakeholders preferred to receive genomic information related to serious or life-threatening health conditions through direct contact (69.5%) with a health professional, i.e. face-to-face consultation or telephone consultation (82.4%). Persons with mental disorders and relatives did not differ in their attitudes from the other stakeholder groups.

CONCLUSION: The findings illustrate that the stakeholders want to be more actively involved and consider consent as a reciprocal transaction between the involved subjects and the researchers in the project. The results highlight the importance of collaboration between researchers and clinical geneticists as the latter are trained, through their education and clinical experience, to return and explain genomic data to patients, relatives, and research subjects.

Original languageEnglish
JournalEuropean psychiatry : the journal of the Association of European Psychiatrists
Volume55
Pages (from-to)29-35
Number of pages7
ISSN0924-9338
DOIs
Publication statusPublished - 2019

ID: 55553711